MedTrace Logo

Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

NCT04326933 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-02-22

No results posted yet for this study

Summary

Determine the effects of tyrosine kinase Inhibitors on liver enzymes and electrolytes in relation to hematologic response in patients with chronic phase chronic meyloid leukemia.. Assiut University Hospital insight..

Conditions

  • Patients Diagnosed as Chronic Meyloid Leukemia

Interventions

DRUG

Tyrosine kinase Inhibitors (Imatinib & Nilotinib)

Administration of tyrosine kinase inhibitors (Imatinib in a dose of 400mg/day \& Nilotinib in adose of 600mg/day)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Howaida A Nafady, Prof. · Not affiliated

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-02-28
Completion
2022-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326933 on ClinicalTrials.gov